Jinhe Biotechnology CO., LTD. (SHE:002688)

SHE:002688 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,471	2,366	2,168	2,117	2,072	1,808
Other Revenue	4.99	4.99	6.04	5.82	5.8	6.56
Revenue	2,476	2,371	2,174	2,123	2,078	1,815
Revenue Growth (YoY)	14.31%	9.04%	2.42%	2.15%	14.51%	1.81%
Cost of Revenue	1,700	1,641	1,572	1,545	1,472	1,216
Gross Profit	776.08	729.97	602.51	577.47	605.66	598.34
Selling, General & Admin	432.13	401.98	367.95	352.78	316.37	308.49
Research & Development	97.06	94	74	82.28	72.25	66.36
Other Operating Expenses	15.01	8.14	5.82	7.75	12.15	12.27
Operating Expenses	559.08	518.11	454.08	444.34	402.65	387.4
Operating Income	217.01	211.85	148.43	133.13	203.01	210.94
Interest Expense	-83.63	-80.34	-60.03	-36.41	-52.34	-60.35
Interest & Investment Income	6.58	6.9	8.37	1.9	1.72	9.48
Currency Exchange Gain (Loss)	8.92	8.92	8.85	40.34	-8.83	-31.58
Other Non Operating Income (Expenses)	-29.82	-28.48	-7.33	-15.79	-4.87	-2.74
EBT Excluding Unusual Items	119.06	118.85	98.29	123.18	138.68	125.77
Impairment of Goodwill	-39.77	-39.77	-5.62	-7.74	-11.04	-8.31
Gain (Loss) on Sale of Investments	-0.78	-1.22	-1.52	-3.94	-	-
Gain (Loss) on Sale of Assets	0.4	0.19	-0.36	-0.25	4.87	-
Asset Writedown	5.2	-1.11	-0.93	-0.46	-1.28	-2.56
Other Unusual Items	23.24	20.83	11.65	8.05	11.69	26
Pretax Income	107.36	97.78	101.5	118.84	142.91	140.91
Income Tax Expense	18.83	13.46	7.06	0.73	20.82	1.71
Earnings From Continuing Operations	88.53	84.32	94.43	118.11	122.09	139.19
Minority Interest in Earnings	17.64	15.88	-7.98	-42.5	-28.1	-21.87
Net Income	106.17	100.2	86.46	75.62	93.99	117.32
Net Income to Common	106.17	100.2	86.46	75.62	93.99	117.32
Net Income Growth	12.14%	15.90%	14.34%	-19.55%	-19.89%	-36.56%
Shares Outstanding (Basic)	772	774	780	780	696	652
Shares Outstanding (Diluted)	772	774	780	780	696	652
Shares Change (YoY)	-1.06%	-0.76%	-0.01%	12.16%	6.74%	2.21%
EPS (Basic)	0.14	0.13	0.11	0.10	0.14	0.18
EPS (Diluted)	0.14	0.13	0.11	0.10	0.14	0.18
EPS Growth	13.34%	16.79%	14.34%	-28.27%	-24.94%	-37.93%
Free Cash Flow	132.67	136.18	-258.45	-277.69	-230.74	54.07
Free Cash Flow Per Share	0.17	0.18	-0.33	-0.36	-0.33	0.08
Dividend Per Share	0.100	0.100	0.100	0.100	-	0.100
Dividend Growth	-	-	-	-	-	-60.00%
Gross Margin	31.34%	30.79%	27.71%	27.20%	29.15%	32.97%
Operating Margin	8.76%	8.94%	6.83%	6.27%	9.77%	11.63%
Profit Margin	4.29%	4.23%	3.98%	3.56%	4.52%	6.46%
Free Cash Flow Margin	5.36%	5.75%	-11.89%	-13.08%	-11.10%	2.98%
EBITDA	405.28	397.04	321.3	282.31	333.98	330.9
EBITDA Margin	16.37%	16.75%	14.78%	13.30%	16.07%	18.23%
D&A For EBITDA	188.27	185.19	172.86	149.18	130.97	119.95
EBIT	217.01	211.85	148.43	133.13	203.01	210.94
EBIT Margin	8.76%	8.94%	6.83%	6.27%	9.77%	11.62%
Effective Tax Rate	17.54%	13.77%	6.96%	0.61%	14.57%	1.21%
Revenue as Reported	2,476	2,371	2,174	2,123	2,078	1,815
Advertising Expenses	-	27.74	20.64	12.16	5.36	2.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.